[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2142490T3 - Ciclopeptolidos. - Google Patents

Ciclopeptolidos.

Info

Publication number
ES2142490T3
ES2142490T3 ES95928473T ES95928473T ES2142490T3 ES 2142490 T3 ES2142490 T3 ES 2142490T3 ES 95928473 T ES95928473 T ES 95928473T ES 95928473 T ES95928473 T ES 95928473T ES 2142490 T3 ES2142490 T3 ES 2142490T3
Authority
ES
Spain
Prior art keywords
pct
leu
sec
adhesion molecule
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95928473T
Other languages
English (en)
Inventor
Michael Morris Dreyfuss
Carolyn Ann Foster
Hans-Ulrich Naegeli
Berndt Oberhauser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415168A external-priority patent/GB9415168D0/en
Priority claimed from GBGB9504332.9A external-priority patent/GB9504332D0/en
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2142490T3 publication Critical patent/ES2142490T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)

Abstract

CICLOPEPTOLIDOS DE FORMULA (I), EN LA QUE A, B, R 1 LEU, LEU, C, X E Y, SON COMO SE DEFINEN A CONTINUACION, SON INHIBIDORES DE LA EXPRESION DE LAS MOLECULAS DE ADHESION Y SON UTILES POR TANTO EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS Y OTRAS, QUE SE DEBEN A NIVELES INCREMENTADOS DE EXPRESION DE LAS MOLECULAS DE ADHESION.
ES95928473T 1994-07-27 1995-07-26 Ciclopeptolidos. Expired - Lifetime ES2142490T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9415168A GB9415168D0 (en) 1994-07-27 1994-07-27 Organic compounds
GBGB9504332.9A GB9504332D0 (en) 1995-03-03 1995-03-03 Organic compounds

Publications (1)

Publication Number Publication Date
ES2142490T3 true ES2142490T3 (es) 2000-04-16

Family

ID=26305345

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95928473T Expired - Lifetime ES2142490T3 (es) 1994-07-27 1995-07-26 Ciclopeptolidos.

Country Status (26)

Country Link
US (1) US6013627A (es)
EP (1) EP0775158B1 (es)
JP (1) JP3425763B2 (es)
KR (1) KR100378974B1 (es)
CN (1) CN1116304C (es)
AT (1) ATE187461T1 (es)
AU (1) AU702332B2 (es)
BR (1) BR9508342A (es)
CA (1) CA2192786C (es)
CY (1) CY2225B1 (es)
CZ (1) CZ289311B6 (es)
DE (1) DE69513837T2 (es)
DK (1) DK0775158T3 (es)
ES (1) ES2142490T3 (es)
FI (1) FI970279A0 (es)
GR (1) GR3032698T3 (es)
HK (1) HK1014011A1 (es)
HU (1) HUT77388A (es)
MX (1) MX9606494A (es)
NO (1) NO970340D0 (es)
NZ (1) NZ291168A (es)
PL (1) PL181990B1 (es)
PT (1) PT775158E (es)
RU (1) RU2155772C2 (es)
SK (1) SK11797A3 (es)
WO (1) WO1996003430A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) * 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
US6011136A (en) * 1995-11-21 2000-01-04 Novartis Ag Cyclopeptolides
WO1999014082A1 (en) 1996-09-18 1999-03-25 Minnesota Mining And Manufacturing Company Adhesively-bonded inflatable restraint and method of making
US6365619B1 (en) 1999-07-22 2002-04-02 Novartis Ag Treatment of arteriosclerosis
ES2219388T3 (es) * 1999-08-24 2004-12-01 Ariad Gene Therapeutics, Inc. 28-epi-rapalogos.
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
WO2002034283A2 (en) * 2000-10-27 2002-05-02 Novartis Ag Vegh inhibitors and their use
GB0028367D0 (en) * 2000-11-21 2001-01-03 Celltech Chiroscience Ltd Chemical compounds
GB0101598D0 (en) * 2001-01-22 2001-03-07 Novartis Ag Organic compounds
DE60331367D1 (de) 2002-12-30 2010-04-01 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
CA2711765A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
CA2905229C (en) 2013-06-11 2023-10-10 Clontech Laboratories, Inc. Protein enriched microvesicles and methods of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443367A (en) * 1982-04-08 1984-04-17 Monsanto Company Peptide and peptolide substrates for mammalian collagenase
US4425428A (en) * 1982-04-08 1984-01-10 Monsanto Company Novel peptide and peptolide substrates for mammalian collagenase
DE3851268T2 (de) * 1987-06-19 1995-01-26 Sandoz Ag Zyklische Peptolide.
DE3832059A1 (de) * 1988-09-21 1990-03-29 Howaldtswerke Deutsche Werft Tauchtiefengesteuerte ausblasventil-einrichtung
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
NZ291168A (en) 1998-06-26
FI970279A (fi) 1997-01-23
AU702332B2 (en) 1999-02-18
US6013627A (en) 2000-01-11
HUT77388A (hu) 1998-04-28
DE69513837D1 (de) 2000-01-13
RU2155772C2 (ru) 2000-09-10
NO970340L (no) 1997-01-27
GR3032698T3 (en) 2000-06-30
EP0775158B1 (en) 1999-12-08
PL181990B1 (pl) 2001-10-31
HK1014011A1 (en) 1999-09-17
KR100378974B1 (ko) 2003-10-08
JP3425763B2 (ja) 2003-07-14
NO970340D0 (no) 1997-01-27
DK0775158T3 (da) 2000-05-22
CN1154705A (zh) 1997-07-16
PT775158E (pt) 2000-05-31
BR9508342A (pt) 1997-10-21
WO1996003430A1 (en) 1996-02-08
JPH10504540A (ja) 1998-05-06
ATE187461T1 (de) 1999-12-15
CA2192786A1 (en) 1996-02-08
CN1116304C (zh) 2003-07-30
CY2225B1 (en) 2003-04-18
FI970279A0 (fi) 1997-01-23
CZ22197A3 (en) 1997-05-14
PL317349A1 (en) 1997-04-01
SK11797A3 (en) 1997-07-09
AU3222195A (en) 1996-02-22
CA2192786C (en) 2009-06-16
DE69513837T2 (de) 2000-05-18
MX9606494A (es) 1997-03-29
CZ289311B6 (cs) 2001-12-12
EP0775158A1 (en) 1997-05-28

Similar Documents

Publication Publication Date Title
DE69124371D1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
DE69729583D1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren
ATE196765T1 (de) Dihydrobenzofurane
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
DE69634045D1 (de) Antithrombotische diamine
RO117913B1 (ro) Derivaţi de n-[(amino-(imino)metil)fenil]propil amide substituite, compoziţie farmaceutică care îi conţine şi metodă de tratament
DE69513837D1 (de) Cyklopeptolide
IL116231A (en) Dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals as thrombin inhibitors
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
ATE212996T1 (de) Anthracyclin-derivate
ES2156212T3 (es) Derivados de azabicicloheptano n-substituidos como neurolepticos, etc.
BR9808210A (pt) Befeniloxazolinas dissubstituìdas
MY115877A (en) Cyclopeptolides
ATE268768T1 (de) Antithrombosemittel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 775158

Country of ref document: ES